Top Eminent Healthcare Group Limited (“TE Healthcare”) reported that shareholders and proxies present at the 8 May 2026 Annual General Meeting (AGM) cast 1.51 billion votes—100.00% in favour—for every resolution on the agenda, resulting in the full passage of all ordinary resolutions by poll.

Key outcomes

1. FY2025 Results Adopted • Shareholders approved the audited consolidated financial statements, directors’ report and independent auditor’s report for the year ended 31 December 2025 with 1.51 billion votes for and none against.

2. Board Composition Affirmed • Re-election of Director Li Jiong (Non-Executive) and Independent Non-Executive Directors Zhou Jiannan, Hu Zhaoxia and Lyu Aiping each received 100.00% support, safeguarding board continuity. • The board was authorised to determine directors’ remuneration with unanimous backing.

3. Auditor Reappointment • BDO Limited was re-appointed as external auditor, and the board was authorised to fix its remuneration; 100.00% of votes supported the resolution.

4. Capital Management Flexibility • Shareholders granted the board two general and unconditional mandates: – Issue mandate: authority to allot, issue and dispose of new shares up to 10% of existing issued share capital at no more than a 10% discount to the benchmarked price. – Repurchase mandate: authority to buy back up to 10% of issued shares. • Both mandates were backed by 100.00% of votes cast.

Participation and governance

• The AGM was attended by all nine board members, either in person or via electronic means. • Union Registrars Limited acted as scrutineer for vote counting. • As of the meeting date, TE Healthcare had 2.03 billion issued shares; the 1.51 billion votes cast indicate a shareholder turnout of approximately 74%. • No shareholders were required to abstain, and no dissent or abstention was recorded on any item.

The unanimous endorsement underscores shareholder confidence in TE Healthcare’s current governance structure, audited results and capital management strategy.